The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-MIND: A phase Ib, open-label, randomized study to assess safety of tafasitamab (tafa) or tafa + lenalidomide (LEN) in addition to R-CHOP in patients with newly diagnosed DLBCL.
 
David Belada
Consulting or Advisory Role - Debiopharm Group; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche; Takeda
Research Funding - Archigen Biotech (Inst); Dr. Reddy's (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); MorphoSys (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Takeda
 
Katerina Kopeckova
No Relationships to Disclose
 
Juan Miguel Bergua
No Relationships to Disclose
 
Marc André
Consulting or Advisory Role - BMSi; Takeda
Research Funding - Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Roche
 
Ernesto Perez Persona
Consulting or Advisory Role - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen
Speakers' Bureau - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; Janssen; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; Janssen; Jazz Pharmaceuticals; Roche
 
Petra Pichler
No Relationships to Disclose
 
Pia Klöpfer
Employment - MorphoSys
 
Bettina Brackertz
Employment - MorphoSys
 
Emanuel Lohrmann
Employment - MorphoSys
 
Anirban Lahiry
Employment - MorphoSys
 
Neha Shah
Employment - MorphoSys
 
Wolfram Brugger
Employment - MorphoSys
 
John M. Burke
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; Bayer; BeiGene; Epizyme; Genentech/Roche; Kura Oncology; Kymera; MorphoSys; Novartis; Seagen; Verastem
Speakers' Bureau - Beigene; Seagen
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group; Genentech (Inst); Kite/Gilead; MorphoSys (Inst); Selvita
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)